James Wallis is an accomplished neuroscience researcher and accomplished Pharma Equity Research Analyst. He studied his PhD in neuroscience and has since gone on to take the CFA level 1 academic certification. He gained his Masters in Pharmacology at the University of Bath and actively involved in portfolio insights and analytics as a Manager at GSK. Previously, he's worked multiple research positions in Pfizer and GSK with a focus on the investigation of neurological mechanisms for medicinal research. His expertise and skills combine research and analytical skills in neuroscience and the pharmaceutical industry.